MedPath

Pioglitazone for bipolar mixed or depressive episode

Phase 2
Conditions
Bipolar disorder.
F31.3-6
Registration Number
IRCT201211211556N46
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

The patients who were diagnosed with depressive (Hamilton rating scale >=20) or mixed (both Hamilton >=20 and Mania>=18) based on DSM-IV-TR criteria will be included in the study after obtaining informed consent.

Exclusion criteria
1. Disorders in other axes
2. Other psychotropic drugs
3. Taking antidepressants in the past month
4. Thyroid disorder
5. ECT in the previous two months
6. History of cardiovascular disorders
7. Pregnant or lactating women

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in depression. Timepoint: Week 6. Method of measurement: Hamilton Depression Rating Scale.
Secondary Outcome Measures
NameTimeMethod
Reduction in depression. Timepoint: Week 2 and 4. Method of measurement: Hamilton Depression Rating Scale.;Reduction in mania. Timepoint: Weeks 2, 4 and 6. Method of measurement: Young Mania Rating Scale.
© Copyright 2025. All Rights Reserved by MedPath